Compound ID | 2815
Class: Drug efflux pump inhibitor
| Agent Type: | Synthetic; Small molecule; Direct acting; Antibiotic adjuvant; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Efflux pump inhibitor. Binds to AcrB of the RND efflux pump (confirmed not to disrupt integrity or potential of cell membrane) |
| Target Pathogen: | Active against Salmonella enterica |
| Description: | Synthetic compound identified from the screening platform SAFIRE (Screen for Anti-Infectives using Fluorescence microscopy of intracellular Enterobacteriaceae); active against Gram-negatives within a host cell (i.e. macrophage and epithelial cells); does not show activity in standard laboratory medium; shows synergistic effect with erythromycin or ciprofloxacin in macrophages |
| Institute where first reported: | Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, Colorado, USA; Cleveland Center for Membrane and Structural Biology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA; Department of Pharmacology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA |
| Year first mentioned: | 2018 |
| Development status: | Experimental |